nodes	percent_of_prediction	percent_of_DWPC	metapath
Octreotide—MPO—Dapsone—leprosy	0.813	1	CbGbCtD
Octreotide—Hypochromic anaemia—Thalidomide—leprosy	0.00393	0.0221	CcSEcCtD
Octreotide—Hernia—Thalidomide—leprosy	0.00325	0.0183	CcSEcCtD
Octreotide—Sinus bradycardia—Thalidomide—leprosy	0.00311	0.0175	CcSEcCtD
Octreotide—Hypothyroidism—Thalidomide—leprosy	0.00237	0.0134	CcSEcCtD
Octreotide—Nail disorder—Thalidomide—leprosy	0.00235	0.0132	CcSEcCtD
Octreotide—Galactorrhoea—Thalidomide—leprosy	0.00235	0.0132	CcSEcCtD
Octreotide—Intestinal obstruction—Thalidomide—leprosy	0.00223	0.0126	CcSEcCtD
Octreotide—Seborrhoeic dermatitis—Thalidomide—leprosy	0.00223	0.0126	CcSEcCtD
Octreotide—Menstrual disorder—Thalidomide—leprosy	0.00223	0.0126	CcSEcCtD
Octreotide—Burning sensation—Thalidomide—leprosy	0.00219	0.0123	CcSEcCtD
Octreotide—Neuralgia—Thalidomide—leprosy	0.00219	0.0123	CcSEcCtD
Octreotide—Metrorrhagia—Thalidomide—leprosy	0.00213	0.012	CcSEcCtD
Octreotide—Psychotic disorder—Dapsone—leprosy	0.00211	0.0119	CcSEcCtD
Octreotide—Neuritis—Thalidomide—leprosy	0.00204	0.0115	CcSEcCtD
Octreotide—Cholestasis—Thalidomide—leprosy	0.00201	0.0113	CcSEcCtD
Octreotide—Nasopharyngitis—Dapsone—leprosy	0.00193	0.0109	CcSEcCtD
Octreotide—Muscular weakness—Dapsone—leprosy	0.0019	0.0107	CcSEcCtD
Octreotide—Tingling sensation—Thalidomide—leprosy	0.00189	0.0107	CcSEcCtD
Octreotide—Influenza—Dapsone—leprosy	0.00187	0.0105	CcSEcCtD
Octreotide—Petechiae—Thalidomide—leprosy	0.00185	0.0104	CcSEcCtD
Octreotide—Endocrine disorder—Thalidomide—leprosy	0.00184	0.0103	CcSEcCtD
Octreotide—Numbness—Thalidomide—leprosy	0.00184	0.0103	CcSEcCtD
Octreotide—Pancreatitis—Dapsone—leprosy	0.00183	0.0103	CcSEcCtD
Octreotide—Acne—Thalidomide—leprosy	0.00181	0.0102	CcSEcCtD
Octreotide—Sensory loss—Thalidomide—leprosy	0.00176	0.0099	CcSEcCtD
Octreotide—Jaundice cholestatic—Thalidomide—leprosy	0.00173	0.00976	CcSEcCtD
Octreotide—Amenorrhoea—Thalidomide—leprosy	0.00173	0.00976	CcSEcCtD
Octreotide—Viral infection—Thalidomide—leprosy	0.00169	0.0095	CcSEcCtD
Octreotide—SSTR2—eye—leprosy	0.00169	0.185	CbGeAlD
Octreotide—Cellulitis—Thalidomide—leprosy	0.00167	0.00943	CcSEcCtD
Octreotide—Hyperbilirubinaemia—Thalidomide—leprosy	0.00167	0.00943	CcSEcCtD
Octreotide—Arthropathy—Thalidomide—leprosy	0.00167	0.00943	CcSEcCtD
Octreotide—SSTR4—nervous system—leprosy	0.00166	0.182	CbGeAlD
Octreotide—Herpes simplex—Thalidomide—leprosy	0.00165	0.00931	CcSEcCtD
Octreotide—Drug interaction—Thalidomide—leprosy	0.00164	0.00925	CcSEcCtD
Octreotide—Neuropathy peripheral—Dapsone—leprosy	0.00163	0.00919	CcSEcCtD
Octreotide—Hearing impaired—Thalidomide—leprosy	0.0016	0.00901	CcSEcCtD
Octreotide—Sinusitis—Dapsone—leprosy	0.00156	0.00879	CcSEcCtD
Octreotide—Phosphatase alkaline increased—Thalidomide—leprosy	0.00152	0.00858	CcSEcCtD
Octreotide—Eructation—Thalidomide—leprosy	0.0015	0.00843	CcSEcCtD
Octreotide—Hyperkalaemia—Thalidomide—leprosy	0.0015	0.00843	CcSEcCtD
Octreotide—Pharyngitis—Dapsone—leprosy	0.00148	0.00835	CcSEcCtD
Octreotide—Candida infection—Thalidomide—leprosy	0.00145	0.00819	CcSEcCtD
Octreotide—Neuropathy—Thalidomide—leprosy	0.00143	0.00805	CcSEcCtD
Octreotide—Cramps of lower extremities—Thalidomide—leprosy	0.0014	0.00788	CcSEcCtD
Octreotide—Tinnitus—Dapsone—leprosy	0.00139	0.00785	CcSEcCtD
Octreotide—Gynaecomastia—Thalidomide—leprosy	0.00136	0.00767	CcSEcCtD
Octreotide—SSTR3—nervous system—leprosy	0.00135	0.148	CbGeAlD
Octreotide—Hyperkinesia—Thalidomide—leprosy	0.00133	0.00748	CcSEcCtD
Octreotide—Erythema—Dapsone—leprosy	0.0013	0.00733	CcSEcCtD
Octreotide—Thrombophlebitis—Thalidomide—leprosy	0.00128	0.00719	CcSEcCtD
Octreotide—Diabetes mellitus—Thalidomide—leprosy	0.00127	0.00716	CcSEcCtD
Octreotide—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.00127	0.00716	CcSEcCtD
Octreotide—Gastroenteritis—Thalidomide—leprosy	0.00125	0.00703	CcSEcCtD
Octreotide—Deafness—Thalidomide—leprosy	0.00124	0.00696	CcSEcCtD
Octreotide—Vision blurred—Dapsone—leprosy	0.00123	0.0069	CcSEcCtD
Octreotide—Cardiac failure congestive—Thalidomide—leprosy	0.00122	0.00687	CcSEcCtD
Octreotide—Injury—Thalidomide—leprosy	0.0012	0.00677	CcSEcCtD
Octreotide—MPO—blood vessel—leprosy	0.0012	0.132	CbGeAlD
Octreotide—Amnesia—Thalidomide—leprosy	0.00118	0.00663	CcSEcCtD
Octreotide—Vertigo—Dapsone—leprosy	0.00117	0.00658	CcSEcCtD
Octreotide—Visual disturbance—Thalidomide—leprosy	0.00117	0.00657	CcSEcCtD
Octreotide—Arthritis—Thalidomide—leprosy	0.00114	0.00641	CcSEcCtD
Octreotide—Cough—Dapsone—leprosy	0.00113	0.00639	CcSEcCtD
Octreotide—Hypoglycaemia—Thalidomide—leprosy	0.00113	0.00638	CcSEcCtD
Octreotide—Osteoarthritis—Thalidomide—leprosy	0.00111	0.00623	CcSEcCtD
Octreotide—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.00111	0.00623	CcSEcCtD
Octreotide—Pain in extremity—Thalidomide—leprosy	0.00111	0.00623	CcSEcCtD
Octreotide—Psychotic disorder—Thalidomide—leprosy	0.00108	0.00608	CcSEcCtD
Octreotide—SSTR1—nervous system—leprosy	0.00107	0.117	CbGeAlD
Octreotide—Tachycardia—Dapsone—leprosy	0.00104	0.00583	CcSEcCtD
Octreotide—Dehydration—Thalidomide—leprosy	0.00103	0.00579	CcSEcCtD
Octreotide—Dry skin—Thalidomide—leprosy	0.00101	0.00571	CcSEcCtD
Octreotide—Cramp muscle—Thalidomide—leprosy	0.000996	0.00561	CcSEcCtD
Octreotide—Muscular weakness—Thalidomide—leprosy	0.000975	0.00549	CcSEcCtD
Octreotide—Abdominal distension—Thalidomide—leprosy	0.000962	0.00542	CcSEcCtD
Octreotide—Insomnia—Dapsone—leprosy	0.00096	0.00541	CcSEcCtD
Octreotide—Influenza—Thalidomide—leprosy	0.000955	0.00538	CcSEcCtD
Octreotide—Bronchospasm—Thalidomide—leprosy	0.00094	0.00529	CcSEcCtD
Octreotide—Pancreatitis—Thalidomide—leprosy	0.000937	0.00528	CcSEcCtD
Octreotide—Bronchitis—Thalidomide—leprosy	0.000919	0.00518	CcSEcCtD
Octreotide—SSTR2—nervous system—leprosy	0.000907	0.0995	CbGeAlD
Octreotide—Upper respiratory tract infection—Thalidomide—leprosy	0.000888	0.005	CcSEcCtD
Octreotide—Pollakiuria—Thalidomide—leprosy	0.000883	0.00497	CcSEcCtD
Octreotide—Weight increased—Thalidomide—leprosy	0.00087	0.0049	CcSEcCtD
Octreotide—Gastrointestinal pain—Dapsone—leprosy	0.000868	0.00489	CcSEcCtD
Octreotide—Weight decreased—Thalidomide—leprosy	0.000864	0.00487	CcSEcCtD
Octreotide—Hyperglycaemia—Thalidomide—leprosy	0.000862	0.00485	CcSEcCtD
Octreotide—Pneumonia—Thalidomide—leprosy	0.000857	0.00483	CcSEcCtD
Octreotide—Drowsiness—Thalidomide—leprosy	0.000852	0.0048	CcSEcCtD
Octreotide—Depression—Thalidomide—leprosy	0.000849	0.00478	CcSEcCtD
Octreotide—Body temperature increased—Dapsone—leprosy	0.000839	0.00473	CcSEcCtD
Octreotide—Abdominal pain—Dapsone—leprosy	0.000839	0.00473	CcSEcCtD
Octreotide—Neuropathy peripheral—Thalidomide—leprosy	0.000835	0.0047	CcSEcCtD
Octreotide—Conjunctivitis—Thalidomide—leprosy	0.000828	0.00466	CcSEcCtD
Octreotide—Haematuria—Thalidomide—leprosy	0.000812	0.00458	CcSEcCtD
Octreotide—Epistaxis—Thalidomide—leprosy	0.000804	0.00453	CcSEcCtD
Octreotide—Sinusitis—Thalidomide—leprosy	0.000799	0.0045	CcSEcCtD
Octreotide—Bradycardia—Thalidomide—leprosy	0.000779	0.00439	CcSEcCtD
Octreotide—Rhinitis—Thalidomide—leprosy	0.000767	0.00432	CcSEcCtD
Octreotide—Hepatitis—Thalidomide—leprosy	0.000765	0.00431	CcSEcCtD
Octreotide—Hypoaesthesia—Thalidomide—leprosy	0.000761	0.00429	CcSEcCtD
Octreotide—Pharyngitis—Thalidomide—leprosy	0.000759	0.00428	CcSEcCtD
Octreotide—Oedema peripheral—Thalidomide—leprosy	0.000753	0.00424	CcSEcCtD
Octreotide—Visual impairment—Thalidomide—leprosy	0.000737	0.00415	CcSEcCtD
Octreotide—Tinnitus—Thalidomide—leprosy	0.000713	0.00402	CcSEcCtD
Octreotide—Cardiac disorder—Thalidomide—leprosy	0.00071	0.004	CcSEcCtD
Octreotide—Immune system disorder—Thalidomide—leprosy	0.000691	0.00389	CcSEcCtD
Octreotide—Arrhythmia—Thalidomide—leprosy	0.000683	0.00385	CcSEcCtD
Octreotide—Alopecia—Thalidomide—leprosy	0.000676	0.00381	CcSEcCtD
Octreotide—Vomiting—Dapsone—leprosy	0.000675	0.0038	CcSEcCtD
Octreotide—Mental disorder—Thalidomide—leprosy	0.00067	0.00377	CcSEcCtD
Octreotide—Malnutrition—Thalidomide—leprosy	0.000666	0.00375	CcSEcCtD
Octreotide—Headache—Dapsone—leprosy	0.000665	0.00375	CcSEcCtD
Octreotide—Flatulence—Thalidomide—leprosy	0.000656	0.0037	CcSEcCtD
Octreotide—Tension—Thalidomide—leprosy	0.000653	0.00368	CcSEcCtD
Octreotide—Nervousness—Thalidomide—leprosy	0.000647	0.00364	CcSEcCtD
Octreotide—Back pain—Thalidomide—leprosy	0.000644	0.00363	CcSEcCtD
Octreotide—Muscle spasms—Thalidomide—leprosy	0.00064	0.00361	CcSEcCtD
Octreotide—Nausea—Dapsone—leprosy	0.00063	0.00355	CcSEcCtD
Octreotide—Vision blurred—Thalidomide—leprosy	0.000627	0.00353	CcSEcCtD
Octreotide—Tremor—Thalidomide—leprosy	0.000624	0.00351	CcSEcCtD
Octreotide—Ill-defined disorder—Thalidomide—leprosy	0.000618	0.00348	CcSEcCtD
Octreotide—Anaemia—Thalidomide—leprosy	0.000615	0.00347	CcSEcCtD
Octreotide—Agitation—Thalidomide—leprosy	0.000612	0.00345	CcSEcCtD
Octreotide—Malaise—Thalidomide—leprosy	0.0006	0.00338	CcSEcCtD
Octreotide—Vertigo—Thalidomide—leprosy	0.000598	0.00337	CcSEcCtD
Octreotide—Syncope—Thalidomide—leprosy	0.000597	0.00336	CcSEcCtD
Octreotide—Palpitations—Thalidomide—leprosy	0.000588	0.00331	CcSEcCtD
Octreotide—Loss of consciousness—Thalidomide—leprosy	0.000585	0.0033	CcSEcCtD
Octreotide—Cough—Thalidomide—leprosy	0.000581	0.00327	CcSEcCtD
Octreotide—Convulsion—Thalidomide—leprosy	0.000577	0.00325	CcSEcCtD
Octreotide—Hypertension—Thalidomide—leprosy	0.000575	0.00324	CcSEcCtD
Octreotide—Chest pain—Thalidomide—leprosy	0.000567	0.00319	CcSEcCtD
Octreotide—Myalgia—Thalidomide—leprosy	0.000567	0.00319	CcSEcCtD
Octreotide—Arthralgia—Thalidomide—leprosy	0.000567	0.00319	CcSEcCtD
Octreotide—Anxiety—Thalidomide—leprosy	0.000565	0.00318	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000563	0.00317	CcSEcCtD
Octreotide—Discomfort—Thalidomide—leprosy	0.00056	0.00315	CcSEcCtD
Octreotide—MPO—skin of body—leprosy	0.000555	0.0609	CbGeAlD
Octreotide—Dry mouth—Thalidomide—leprosy	0.000554	0.00312	CcSEcCtD
Octreotide—Oedema—Thalidomide—leprosy	0.000543	0.00306	CcSEcCtD
Octreotide—Infection—Thalidomide—leprosy	0.00054	0.00304	CcSEcCtD
Octreotide—Shock—Thalidomide—leprosy	0.000535	0.00301	CcSEcCtD
Octreotide—Nervous system disorder—Thalidomide—leprosy	0.000533	0.003	CcSEcCtD
Octreotide—Thrombocytopenia—Thalidomide—leprosy	0.000532	0.003	CcSEcCtD
Octreotide—Tachycardia—Thalidomide—leprosy	0.00053	0.00299	CcSEcCtD
Octreotide—Skin disorder—Thalidomide—leprosy	0.000528	0.00297	CcSEcCtD
Octreotide—Hyperhidrosis—Thalidomide—leprosy	0.000525	0.00296	CcSEcCtD
Octreotide—Anorexia—Thalidomide—leprosy	0.000518	0.00292	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Thalidomide—leprosy	0.000495	0.00279	CcSEcCtD
Octreotide—Insomnia—Thalidomide—leprosy	0.000491	0.00277	CcSEcCtD
Octreotide—Paraesthesia—Thalidomide—leprosy	0.000488	0.00275	CcSEcCtD
Octreotide—Dyspnoea—Thalidomide—leprosy	0.000484	0.00273	CcSEcCtD
Octreotide—Somnolence—Thalidomide—leprosy	0.000483	0.00272	CcSEcCtD
Octreotide—Dyspepsia—Thalidomide—leprosy	0.000478	0.00269	CcSEcCtD
Octreotide—Decreased appetite—Thalidomide—leprosy	0.000472	0.00266	CcSEcCtD
Octreotide—Gastrointestinal disorder—Thalidomide—leprosy	0.000469	0.00264	CcSEcCtD
Octreotide—Fatigue—Thalidomide—leprosy	0.000468	0.00264	CcSEcCtD
Octreotide—Pain—Thalidomide—leprosy	0.000465	0.00262	CcSEcCtD
Octreotide—Constipation—Thalidomide—leprosy	0.000465	0.00262	CcSEcCtD
Octreotide—Feeling abnormal—Thalidomide—leprosy	0.000448	0.00252	CcSEcCtD
Octreotide—Gastrointestinal pain—Thalidomide—leprosy	0.000444	0.0025	CcSEcCtD
Octreotide—Urticaria—Thalidomide—leprosy	0.000432	0.00243	CcSEcCtD
Octreotide—Body temperature increased—Thalidomide—leprosy	0.00043	0.00242	CcSEcCtD
Octreotide—Abdominal pain—Thalidomide—leprosy	0.00043	0.00242	CcSEcCtD
Octreotide—Hypersensitivity—Thalidomide—leprosy	0.0004	0.00225	CcSEcCtD
Octreotide—Asthenia—Thalidomide—leprosy	0.00039	0.0022	CcSEcCtD
Octreotide—Pruritus—Thalidomide—leprosy	0.000384	0.00217	CcSEcCtD
Octreotide—Diarrhoea—Thalidomide—leprosy	0.000372	0.00209	CcSEcCtD
Octreotide—Dizziness—Thalidomide—leprosy	0.000359	0.00202	CcSEcCtD
Octreotide—MPO—testis—leprosy	0.00035	0.0384	CbGeAlD
Octreotide—Vomiting—Thalidomide—leprosy	0.000345	0.00195	CcSEcCtD
Octreotide—MPO—nervous system—leprosy	0.000343	0.0377	CbGeAlD
Octreotide—Rash—Thalidomide—leprosy	0.000343	0.00193	CcSEcCtD
Octreotide—Dermatitis—Thalidomide—leprosy	0.000342	0.00193	CcSEcCtD
Octreotide—Headache—Thalidomide—leprosy	0.00034	0.00192	CcSEcCtD
Octreotide—Nausea—Thalidomide—leprosy	0.000323	0.00182	CcSEcCtD
